• Updated: Certara Launches BaseCase Data Studio, Enabling Pharma and MedTech Clients to Conduct Advanced Data Analyses During Value-based Product Discussions

    Oct 9, 2019, 12:54 by Michael Croft
    PRINCETON, NJ - Oct 9, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced the launch of BaseCase Data Studio, the newest product for its BaseCase value communications platform
    Full story

  • Life Image and Graticule Announce Partnership to Help Biopharma Realize the Full Potential of Advanced Data in Real World Evidence Programs

    Oct 8, 2019, 12:21 by Michael Croft
    NEWTON, MA - Oct 8, 2019 - Life Image, the world’s largest medical evidence network for clinical and imaging data, today announced a strategic partnership with Graticule, an advanced data firm that provides data subscriptions and advisory services
    Full story

  • The Data On Trial Diversity

    Oct 8, 2019, 09:00 by Michael Croft

    Clinical Research News | A new research study reveals racial and ethnic diversity is still substantially lacking in clinical trials for cancer drugs.

    Full story

  • SCOPE's 2020 Participant Engagement Award Announced, Entries Welcome

    Oct 4, 2019, 12:15 by Michael Croft

    Clinical Research News | Cambridge Healthtech Institute (CHI) is welcoming entries for the SCOPE’s 2020 Participant Engagement Award, an annual award given at the Summit for Clinical Ops Executives (SCOPE).

    Full story

  • Veeva Looks To Assist Clinical Research Sites With Free eRegulatory Solution

    Oct 3, 2019, 07:00 by Michael Croft

    Clinical Research News | Veeva will soon be offering a free, widely available version of their eRegulatory solution SiteVault Enterprise to clinical research sites that would otherwise be unable to invest in a clinical research technology that would assist them in managing regulatory documents and trial information.

    Full story

  • Rho Experts Connect and Engage at Local ACRP Conference

    Oct 2, 2019, 16:43 by Michael Croft
    DURHAM - Oct 2, 2019 - Rho Experts Connect and Engage at Local ACRP ConferenceCRO looks to fill open positions with local talent at industry event WHAT:                 Rho, a full-service contract research organization (CRO) that helps pharmaceutical and biotechnology companies bring their products to market through high-quality clinical research services, will connect with local industry leaders and share insights and expertise at the local conference of the Association of Clinical Research Professionals, ACRP, taking place on October 3-4 in Research Triangle Park
    Full story

  • First Clinical Trial Using Blockchain To Manage Documents

    Oct 2, 2019, 10:45 by Michael Croft

    Clinical Research News | A startup founded by a small team of blockchain enthusiasts is intent on building the world's first clinical research ecosystem enabled by distributed ledger technology and governed by a nonprofit foundation.

    Full story

  • BioIVT Appoints Global Business Strategist Lori Ball as Its Chief Operating Officer

    Oct 2, 2019, 08:30 by Michael Croft
    WESTBURY, NY - Oct 2, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Lori Ball as its chief operating officer (COO)
    Full story

  • Syneos Health Introduces New Book, Why We Resist: The Surprising Truths About Motivating Behavior Change

    Oct 1, 2019, 14:45 by Michael Croft
    MORRISVILLE, NC, U.S.A. - Oct 1, 2019 - Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced the launch of Why We Resist: The Surprising Truths About Motivating Behavior Change
    Full story

  • AstraZeneca selects N-SIDE Suite for Clinical Trials to optimize and monitor clinical trial supply chain

    Oct 1, 2019, 05:37 by Michael Croft
    LOUVAIN LA NEUVE, BELGIUM - Oct 1, 2019 - N-SIDE, provider of innovative software and strategic consulting services, announced that AstraZeneca has signed an agreement to implement the N-SIDE Suite for Clinical Trials
    Full story

  • Nature reports that MR Solutions’ advanced preclinical imaging system helps researchers better understand the ageing processes

    Oct 1, 2019, 05:19 by Michael Croft
    GUILDFORD, UNITED KINGDOM - Oct 1, 2019 - Research published in Nature by the Korea Advanced Institute of Science (KAIST) found that lymphatic vessels in the scull involved in the clearance of cerebrospinal fluid often become compromised with age
    Full story

  • Sharp appoints Sascha Sonnenberg as Global Head of Business Development, Sharp Clinical Services

    Oct 1, 2019, 04:18 by Michael Croft
    RHYMNEY, UK - Sep 26, 2019 - Sharp, part of UDG Healthcare and a leading provider of clinical supply services, has strengthened its leadership team with the appointment of Sascha Sonnenberg as global head of business development for Sharp Clinical Services
    Full story

  • QVigilance announces preferred partnership agreement with ESMS Global

    Oct 1, 2019, 04:15 by Michael Croft
    LONDON, UK - Sep 19, 2019 - QVigilance, a global provider of pharmacovigilance (PV) and risk management services, has announced a preferred partnership agreement with medical information (MI) provider ESMS Global
    Full story

  • Veeva Acquires Crossix For $430M

    Sep 30, 2019, 14:10 by Michael Croft
    Clinical Research News | Veeva Systems announced its acquisition of Crossix Solutions last week. Under the terms of the agreement, Veeva will acquire Crossix for a purchase price of $430 million, paid all in cash, subject to customary purchase price adjustments.
    Full story

  • Signant Health Proudly Sponsors “DISORDER: The Rare Disease Film Festival” to Raise Awareness and Hope for Millions of Families Worldwide

    Sep 30, 2019, 09:38 by Michael Croft
    PHILADELPHIA, UNITED KINGDOM - Sep 30, 2019 - There are 7,000 recognized rare disease conditions that affect between 25 and 30 million people in the United States alone, and the vast majority are totally unknown in the community
    Full story

  • 23andMe Consumer DNA Giant Is Moving Into Clinical Trial Recruitment

    Sep 26, 2019, 16:20 by Michael Croft
    STAT |  23andMe will partner with a fast-growing startup to help match its customers with nearby study sites based on their diseases, demographics, and DNA.
    Full story

  • Shimmer, IQVIA, Certara, and More: News From September 2019

    Sep 26, 2019, 11:00 by Michael Croft

    Clinical Research News | September was full of exciting news in the clinical trial and healthcare community, including partnerships, products, and promotions from Shimmer, IQVIA, Certara, and more.

    Full story

  • FDA Renews Licenses for Synchrogenix’s GlobalSubmit Software to Review and Validate New Drug and Biologics Applications

    Sep 25, 2019, 08:11 by Michael Croft
    PRINCETON, NJ - Sep 25, 2019 - Certara®, the global model-informed drug development and decision support leader, today announced that the US Food and Drug Administration (FDA) has renewed its legacy licenses for Synchrogenix’s electronic Common Technical Document (eCTD) review software, GlobalSubmit REVIEW™ and GlobalSubmit VALIDATE™ for another year
    Full story

  • Site Survey Taps Fears About Complexity, Tool Overload, and Decentralized Trials

    Sep 24, 2019, 08:40 by Michael Croft

    Clinical Research News | A survey conducted by the Society for Clinical Research Sites and sponsored by Oracle highlights clinical researchers’ growing dissatisfaction with redundant software, as well as a shift in how sponsors view the relationship between the site and the patient.

    Full story

  • BioIVT Joins Medicines Discovery Catapult’s Discovery Services Platform to Support Drug Discovery in the UK

    Sep 24, 2019, 08:14 by Michael Croft
    ROYSTON, UK - Sep 24, 2019 - BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has joined UK Medicines Discovery Catapult’s Discovery Services Platform, partnering with other best-in-class service providers to help improve preclinical drug discovery success rates
    Full story
  • «
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189 (current)
  • 190
  • »